Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists-Reference-Cited by-同舟云学术

Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists

Published:2013-04 Issue: Volume: Page:n/a-n/a
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Howlett Trevor A.¹,Willis Debbie¹,Walker Gillian¹,Wass John A.H.¹,Trainer Peter J.¹,

Affiliation:

1. UK Acromegaly Register; Society for Endocrinology; Bristol; UK

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Reference21 articles.

1. Mortality in patients with pituitary disease;Sherlock;Endocrine Reviews,2010

2. An audit of outcome of treatment in acromegaly;Bates;The Quarterly journal of medicine,1993

3. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group;Orme;Journal of Clinical Endocrinology and Metabolism,1998

4. Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly;Ayuk;Journal of Clinical Endocrinology and Metabolism,2004

5. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly;Holdaway;European Journal of Endocrinology,2008

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time to first remission and survival in patients with acromegaly: Evidence from the UK Acromegaly Register Study (UKAR);Clinical Endocrinology;2024-07-16

2. Growth hormone receptor antagonist pegvisomant and its role in the medical therapy of growth hormone excess;Best Practice & Research Clinical Endocrinology & Metabolism;2024-07

3. Real-world value of cabergoline in the treatment of acromegaly;Best Practice & Research Clinical Endocrinology & Metabolism;2024-07

4. Targeting RACGAP1 Suppresses Growth Hormone Pituitary Adenoma Growth;2024-05-08

5. Increased mortality in acromegaly is due to vascular and respiratory disease and is normalised by control of GH levels—A retrospective analysis from the UK Acromegaly Register 1970–2016;Clinical Endocrinology;2024-04-23